News from aratana therapeutics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 02, 2016, 09:00 ET Aratana Therapeutics to Present at Bank of America Merrill Lynch Healthcare Conference

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Apr 25, 2016, 16:10 ET Aratana Therapeutics to Discuss Global Strategic Collaboration with Elanco Animal Health

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Apr 25, 2016, 16:05 ET Aratana, Elanco Announce Global Strategic Collaboration

 Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY) and Aratana Therapeutics, Inc. (NASDAQ: PETX), today announced that...


Apr 14, 2016, 16:05 ET Aratana Therapeutics to Report First Quarter 2016 Financial Results

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Mar 31, 2016, 09:00 ET Aratana Therapeutics to Present GALLIPRANT® (grapiprant tablets) Pivotal Data

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Mar 22, 2016, 16:05 ET Aratana Therapeutics Files for Second FDA Approval

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Mar 21, 2016, 14:56 ET Aratana Therapeutics Granted First FDA Approval

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Mar 14, 2016, 16:05 ET Aratana Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Mar 02, 2016, 17:00 ET Aratana Therapeutics to Present at Barclays Healthcare Conference

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Feb 23, 2016, 16:15 ET Aratana Therapeutics to Report Fourth Quarter and Full Year 2015 Financial Results

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Feb 23, 2016, 08:40 ET Aratana Therapeutics Receives Technical Section Complete Letter for Effectiveness for AT-002

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Feb 22, 2016, 08:40 ET Aratana Therapeutics Receives Technical Section Complete Letter for Effectiveness for AT-003

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Feb 17, 2016, 16:05 ET Aratana Therapeutics Files for First European Approval

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Jan 25, 2016, 16:44 ET Aratana Therapeutics Files for First FDA Approval

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Dec 15, 2015, 09:26 ET Aratana Therapeutics to Present at Bank of America Merrill Lynch Animal Health Summit

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Nov 20, 2015, 16:01 ET Aratana Therapeutics to Present at Piper Jaffray Healthcare Conference and Bank of America Merrill Lynch Animal Health Summit

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Nov 13, 2015, 08:33 ET Aratana Therapeutics to Present at Stifel 2015 Healthcare Conference

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Nov 05, 2015, 17:01 ET Aratana Therapeutics Reports Third Quarter 2015 Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Oct 29, 2015, 17:30 ET Aratana Therapeutics to Report Third Quarter Results

Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative...


Oct 21, 2015, 08:30 ET Save the Date for Aratana Therapeutics 2015 Investor Day

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Oct 16, 2015, 06:30 ET Aratana Therapeutics Announces a $40 Million Credit Facility

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Sep 24, 2015, 18:00 ET Aratana Therapeutics Provides Product Updates

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Aug 10, 2015, 08:00 ET Aratana Therapeutics Elects Wendy Yarno as Chairman of the Board of Directors

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...


Aug 06, 2015, 16:20 ET Aratana Therapeutics Reports Second Quarter 2015 Results

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative...


Jul 30, 2015, 08:03 ET Aratana Therapeutics Announces Positive Pilot Field Study for AT-016

 Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of...